The effectiveness of surfactants as potentiators of antibiotic activity on several resistant strains of bacteria, selected from clinical sources and laboratory collections, was studied using a tube dilution assay. Bacterial strains included members of the Enterobacteriaceae and staphylococci. Cetyltrimethylammonium bromide (CTAB), Tween 80 (Tw8O), a mixture of n-alkyldimethyl betaines (L14), and alpha-(2,4,5-trichlorophenoxy) propionic acid (TCP) were tested in combination with pencillin G (PenG), methicillin (Met), streptomycin (Sm), polymyxin B (PmB), and chlortetracycline (CTC 
Antimicrobial drugs can affect bacterial cells in any one of various ways including interference with cell wall synthesis, membrane synthesis, and function, or they may enter the cell and interfere with a vital metabolic process. Drug resistance is observed when a population of cells possesses a physical or biochemical means of counteracting the lethal effect of the antimicrobial agent. Among the various resistance mechanisms known, the role played by the cell membrane or envelope structure is perhaps the least understood. Both the physical and chemical properties of the cell membrane, however, would be expected to play an important role in resistance since a drug must first interact with and in many cases pass through this structure.
The gram-negative bacterial cell envelope consists of an inner cytoplasmic membrane, an intermediate cell wall or peptidoglycan layer, and an outer membrane. An outer membrane like that observed in gram-negative cells is absent in gram-positive bacteria. A role for the outer membrane of gram-negative bacteria as a nonspecific permeability barrier has been suggested since treatment of bacterial cells with ethylenediaminetetraacetic acid releases lipopolysaccharide, an outer membrane component, from the cell envelope with a concomitant increase in permeability to various molecules including antibiotics (12) . Related to these observations are studies done with lipopolysaccharide mutants of Escherichia coli strains which have also been observed to have altered antibiotic susceptibilities (11, 22) . Ethylenediaminetetraacetic acid has been reported to potentiate the activity of antibiotics on antibioticresistant bacteria (17, 28) . A potentiating effect of surfactants, molecules possessing both hydrophobic and hydrophilic properties, on antibiotic acitivity has also been reported. Thus Tween 80 (Tw8O) has been shown to enhance the activity of polymyxin B on a strain of Pseudomonas aeruginosa (3) and E. coli (2) . Benzalkonium chloride was reported to potentiate the activity of chloramphenicol on a strain of P. aeruginosa (29) and polyunsaturated fatty acids potentiated the activity of streptomycin on a strain of Staphylococcus aureus (16) . Scherr and Bechtle (19) made the interesting observation that compounds having plant growth-regulating activity, such as alpha-(2,4,5-trichlorophenoxy) propionic acid (TCP), demonstrated potentiation for antibiotics, including polymyxin B, on microorgansims. A marked inhibition of penicillinase induction in S. aureus by anionic surfactants of the aliphatic sulfate type has been reported by Kaminski (10) .
These studies suggest that surfactants, acting as membrane perturbants, might promote easier accessibility of antibiotics to their target sites on or within the bacterial cell. We therefore decided to evaluate -the effectiveness of different classes of surfactants as potentiators of the inhibitory activity of tetracyclines, streptomycin, polymyxins, and penicillins using several antibiotic-resistant strains of bacteria. Surfactants included cetyltrimethylammonium bromide (CTAB), n-alkyldimethyl betaine (L14), Tw80, and TCP. These represent cationic, amphoteric, nonionic, and anionic surfactants, respectively. Possible mechanisms of potentiation were also investigated. Such a study could further define the importance of the bacterial cell membrane or envelope in antibiotic resistance.
Potentiation, as used here, refers to a combination of drugs which increase each other's activity so that the effect is greater than that expected if each one acted alone.
MATERIALS AND METHODS
Bacterial strains. Bacterial strains were initially classified as being resistant or susceptible to an antibiotic according to the disk diffusion method of Bauer et al. (1) .
E. coli Sc8190 and Sc8280 have been described elsewhere (4) . These are related antibiotic-susceptible and -resistant strains, respectively. E. coli Sc8280 harbors resistance factor 222 (R factor 222) which is characterized by sulfonamide-, streptomycin-, chloramphenicol-, and tetracycline-resistant traits. E. coli/Tc was a laboratory strain resistant to tetracyclines and streptomycin. E. coli Sc8599 and Sc8600 were obtained from Edward Meyers (Squibb Institute for Medical Research, Princeton, N.J.). E. coli Sc8600 was a polymyxin-resistant strain developed from Sc8599.
Klebsiella pneumoniae/pm was originally a clinical isolate resistant to tetracyclines and polymyxins and maintained in the laboratory in a lyophylized state.
Proteus mirabilis pm5 and pm5/R+ were obtained from James Punch (Department of Microbiology, Virginia Commonwealth University, Richmond, Va.). These are related strains which are both resistant to the polymyxins. P. mirabilis pm5/R+ also harbors R factor 222 described above. P. mirabilis 190A-1 and Serratia marcescens 164E3 and 164E4 were obtained from Roy Cleeland (Hoffmann-LaRoche, Nutley, N.J. Growth studies. A standard tube dilution assay was developed to investigate the effectiveness of antibiotic-surfactant combinations as growth inhibitors of the antibiotic-resistant strains. Growth studies were carried out in tubes (12 by 75 mm). Stock solutions of inhibitors were diluted into sterile medium and various amounts of these dilutions were added to the assay tubes. Sterile medium was added to each tube to obtain a final volume of 2.0 ml. Stock solutions ofpolymyxin B, penicillin G, methicillin, streptomycin, and Tw8O were prepared in medium just prior to use; chlortetracycline and CTAB were used as 2.0-mg/ml solutions in water; L14 was used as a 0.31% solution in water; TCP was diluted into sterile medium from a 10.0-mg/ml solution in sodium hydroxide.
Inocula were prepared by inoculating 20 ml -of medium with a 16-to 18-h broth culture and incubating at 37 C in a New Brunswick Scientific incubatorshaker until growth reached late logarithmic phase as determined by optical density readings on a Coleman Jr. spectrophotometer at a wave length of 600 nm (OD..o). The culture was chilled in an ice bath and diluted with medium so that 0.1 ml of culture yielded an initial OD..0 of 0.02 per assay tube. Assay tubes were incubated in a rack tilted at a 450 angle in the shaker-incubator. The spectrophotometer was adapted to fit the assay tubes so that turbidimetric measurements of the growth response to various drugs could be easily done. In some experiments, inocula were prepared as described but in the presence of noninhibitory concentrations of surfactant and/or antibiotic. This was done to determine either the effect of surfactant on induction of antibiotic resist-VOL. 8, 1975 on November 3, 2017 by guest http://aac.asm.org/ Downloaded from ance or if pretreatment of cells with surfactant would sensitize the cells to an antibiotic.
Effectiveness of inhibitor was determined by measuring differences in OD at a fixed incubation time between a culture with no drug and one with drug and calculating percentage of inhibiton. The time of incubation for each assay varied with the bacterial strain and was that time when growth of the control culture reached late logarithmic phase (3 to 6 h). Percentage of inhibition was defined as the ratio of the OD of the control culture minus the OD of the inhibited culture to the OD of the control culture minus the OD at the start of incubation. This ratio multiplied by 100 gave the percentage of inhibition.
For initial screening of the effect of the various surfactant-antibiotic combinations, a noninhibitory concentration of surfactant was tested in combination with at least two subinhibitory concentrations of antibiotic. An inhibition of growth by the surfactantantibiotic combination greater than that by the antibiotic alone was taken to indicate potentiation.
To further evaluate those drug combinations which suggested potentiation, a modification of the method of Elion et al. (5) was used. The response (percentage of inhibition) of duplicate cultures to increasing concentrations of antibiotic and surfactant, both alone and in combination, was determined. Doseresponse curves were drawn by plotting the percentage of inhibition against the log,( of the drug concentration. The resulting curves were found to give a straight line relationship between 20 and 80% inhibition. From these curves, the effective drug dose which inhibited growth rate by 50% (ED50) was measured.
The ratio of the ED,0 for the combined drugs to the ED,0 of each drug alone in the inhibitory mixture is the fractional inhibitory concentration. If the sum of the fractional inhibitory concentration of each drug in a combination is equal to 1.0, an additive effect is suggested; if the sum is less than 1.0, potentiation is suggested; and if it is greater than 1.0, there is antagonism.
Measurement of protein synthesis. Protein synthesis was measured as the rate of incorporation of uniformly labeled ["C ]leucine (New England Nuclear, Boston, Mass.; 280 mCi/ml) into the hot trichloroacetic acid-insoluble cell fraction. The uptake tubes contained medium, logarithmic phase cells to give an OD.00 of 0.04, inhibitors, and ["CC]leucine (0.2 ACi/ml) in a total volume of 6.0 ml. Tubes were preincubated at 37 C in a water bath without shaking for 10 min prior to addition of label. Uptake of label was measured at 37 C by transferring, at various time intervals, 1.0-ml samples of each culture to tubes containing an equal volume of 10% trichloroacetic acid. These tubes were heated in a boiling water bath for 5 min and the contents were filtered through 0.45-tim membrane filters (Millipore Corp.) followed by washing the filters with 5% trichloroacetic acid. The filters were dried under a heat lamp and transferred to scintillation vials containing 10 ml of 0.4%
-(5-phenyloxazole)benzeneI in toluene. Radioactivity was measured using a Packard model 2002 liquid scintillation spectrometer. Penicillinase assay. Enzyme activity was assayed according to the acidimetric method described by Rubin and Smith (18) . One unit of penicillinase activity was that amount of enzyme which hydrolyzed 1 Mmol of penicillin G in 1 h (18) . Specific activity was expressed as units of enzyme activity per milligram of protein.
Protein determination. Protein was determined according to the method of Lowry et al. (13) using bovine serum albumin as a standard.
Induction of penicillinase. Staphylococcal cells were subcultured to an OD600 of 0.2 on a New Brunswick shaker-incubator at 37 C at which time the cultures were diluted with an equal volume of sterile medium containing penicillin G to give a final concentration of 100 jtg/ml. In some flasks, CTAB was included in the diluent. Incubation was continued for 2 h. The cultures were chilled in an ice bath, centrifuged at 20,000 x g at 5 C, washed once with 2 mM potassium phosphate buffer, pH 7.6, and resuspended in buffer. Cells were brokin by sonication in an ice bath for 10 min with an MSE ultrasonic disentergrator. The sonicates were clarified by centrifugation as described above and assayed for penicillinase activity and protein as described.
RESULTS
Comparative surfactant susceptibility of antibiotic-susceptible and -resistant strains.
Results presented in Table 1 show that the polymyxin-resistant E. coli Sc8600 strain was more susceptible to the surfactants than the parent Sc8599 strain. The R factor 222 containing E. coli Sc8280 strain did not appear to differ in surfactant susceptibility from the Sc8190 strain whereas P. mirabilis pm5/R+ was found to be less resistant to the surfactants and to polymyxin B than strain pm5. Cross-resistance between polymyxin B and surfactants was evident with the S. marcescens strains. Tw8O was not found to inhibit the growth of any of the bacterial strains up to the highest concentration tested (5.0 mg/ml).
Growth response to antibiotic-surfactant combinations. Figure 1 is an example of the type of growth response observed with combinations of a noninhibitory concentration of surfactant with subinhibitory concentrations of antibiotic. In this case, the potentiating effect of CTAB on chlortetracycline activity is evident. The growth response of other antibiotic-resistant gram-negative strains indicated that CTAB and L14 but not TCP or Tw8O potentiate the activity of chlortetracycline; CTAB, L14, and TCP but not Tw8O potentiate the activity of polymyxin B; none of the surfactants potentiate streptomycin or penicillin G activity. Growth Tetracycline-surfactant combinations. Results presented in Table 2 demonstrated that CTAB and L14, at concentrations which by themselves had little or no effect on bacterial growth rate, decreased the ED,. for chlortetracycline about two-to threefold for all four resistant gram-negative strains.
Subculture of the E. coli Tc and Sc8280 strains in the presence of 1.0,g of chlortetracycline per ml was found to increase the antibiotic resistance level 2.3-fold and 4.3-fold, respectively. No effect of CTAB on this induction could be demonstrated. When chlortetracycline-induced cultures were challenged with chlortetracycline in the presence of 5.0 gg of CTAB per ml, susceptibility to chlortetracycline was found to be similar to that of uninduced cultures challenged without CTAB present ( Table 2) .
The effect of CTAB on the inhibition of protein synthesis in E. coli Tc cultures by tetracycline hydrochloride is presented in Fig.  2 . It can be seen that incorporation of label into the trichloroacetic acid-insoluble material in the presence of CTAB alone was similar to that of the control culture. Tetracycline was observed to initially inhibit protein synthesis for- 7f TC/ml. fractional inhibitory concentrations are less than one. TCP was not effective in potentiating r which time incorporation of label the activity of polymyxin B against K. pneumoa rate similar to that of the control, niae/pm (data not shown) but did potentiate a combined effect of CTAB and antibiotic activity against P. mirabilis 190A-1 was to further inhibit protein syn-and E. coli Sc8600. CTAB and L14 did not Little recovery by'80-min incubation appear to be as effective in enhancing the activity of polymyxin B against E. coli Sc8600, n B-surfactant combinations. Ef-although susceptibility to the antibiotic was combinations on strains of Proteus increased two-to fourfold. Tw8O was found to CTAB. CTAB, up to a concentration of 100 ,ug/ml, was not found to affect penicillinase VOL. 8, 1975 on November 3, 2017 by guest http://aac.asm.org/ Downloaded from Table 3 .
that in many instances several factors may interact each contributing to overall resistance. Experimental evidence presented here suggests that, at least for some antibiotics, cell membranes or envelopes are one of the contributory factors. Although in this study surfactants were found to potentiate the toxic effects of chlortetracycline, penicillin G, and polymyxin B on resistant bacterial strains, this phenomenon is not a general one but depends on the bacterial strain and the type of antibiotic.
The enhancement of the inhibitory effect of chlortetracycline by CTAB and L14 but not TCP and Tw80 suggests the involvement of the quaternary ammonium group of these compounds. Uptake of tetracyclines by bacterial cells has been shown to be an energy-dependent process (6) and resistance to these antibiotics is associated with decreased accumulation of the drug (6, 24) . Higher levels of antibiotic resistance can be induced with low levels of antibiotic (6) . It is possible, therefore, that CTAB and L14 potentiate the activity of chlortetracycline ANTIMICROB. AGENTS CHEMOTHER. either by interfering with the induction mechanism or by overcoming the antibiotic exclusion mechanism. Since it could not be demonstrated that CTAB interfered with the induction mechanism, it appears that the antibiotic exclusion mechanism is affected. In support of this view, it could be demonstrated that the inhibition of protein synthesis in E. coli cells by tetracycline was greater in a cell culture treated with both CTAB and tetracycline than with tetracycline alone (Fig. 2) . This suggests that, in the pressence of CTAB and presumably L14, more antibiotic is taken up by the resistant cells.
Franklin and Foster (7) have recently reported that ethylenediaminetetraacetic acidosmotic shock or ethylenediaminetetraacetic acid treatment alone of tetracycline-resistant cells of E. coli initially increased the inhibition of protein synthesis by tetracyclines followed by recovery of resistance. Similar treatment of susceptible cells showed no such effect. Presumably, resistance components are associated with the outer membrane of the cell envelope since such treatment is known to deplete cells of components of this membrane (12) . With respect to this, it is interesting that Voss (27) has obtained evidence which indicates that cationic surfactants, when added to a suspension of E. coli cells, cause the release of cell surface antigens into the surrounding medium. It is therefore possible that CTAB and L14 disrupt the outer cell membrane leading to increased adsorption and transport of the antibiotic into the cell.
A recent report by Ulitzer (25) on the transport of ,B-galactosides into permeaseless E. coli cells after treatment with noninhibitory concentrations of CTAB may be significant in interpreting the phenomenon of potentiation of chlortetracycline activity. Although these mutant cells were unable to hydrolyze a ,B-galactoside because of a defective transport system, CTAB-treated cells were able to do so (25) . Sodium dodecyl sulfate, benzalkonium chloride, Triton X-100, and Tw8O had no effect on transport (25) . It was suggested that a subunit of the carrier protein is somehow unmasked by the action of CTAB on the outer layer of the cell membrane.
In contrast to their effects on susceptibility to chlortetracycline, CTAB, L14, and TCP were obseived to almost completely sensitize strains of Proteus and Serratia to polymyxin B (Fig. 3) . K. pneumoniae/pm differed from the above mentioned strains in that TCP did not sensitize this strain to polymyxin B. This could be due to the large capsule which is characteristic of such strains. Tw8O was found to sensitize only the polymyxin-resistant strain E. coli Sc8600 to polymyxin B (Table 3 ). This would suggest that the mechanism of resistance in these cells differs in some unknown way from the other strains tested. This effect of Tw8O is similar to the results of Bliss and Warth (2) who reported an increase in the sensitivity of a susceptible strain of E. coli to polymyxin B in the presence of this surfactant. According to Brown and Winsley (3) , Tw8O also potentiates the activity of polymyxin B against P. aeruginosa. It was suggested that Tw8O alters the outer wall structure, allowing easier entry by this antibiotic.
Since the polymyxins are compounds which have the properties of cationic surfactants, resistance to this antibiotic might be expected to confer cross-resistance to other surfactants since these compounds have a common target site, the cell membrane, and presumably a common mechanism of resistance. This was found to be the case with a resistant strain' of Serratia (Table 1) . It was unexpected, however, to find that the polymyxin-resistant E. coli Sc8600 strain was more susceptible to CTAB, L14, and TCP than its parent strain (Table 1) . This, together with the fact that CTAB and L14 were not very effective potentiating agents with this strain, again suggests that the mechanism of polymyxin resistance is different from the other polymyxin-resistant strains.
The presence of R factor 222 in the P. mirabilis strain was also seen to affect susceptibility to the surfactants and polymyxin B. In this instance, P. mirabilis pm5/R+ was found to be concomitantly less resistant to polymyxin B and to CTAB, L14, and TCP than its parent strain (Table 1) . Also, the maximum effective concentrations of L14 and polymyxin B differed from those of the parent (Fig. 3) . It is interesting that the same R factor in E. coli Sc8280 did not alter the susceptibility of this strain to these surfactants. Surface alterations which occur in cells that contain R factors are not known, but this factor apparently affects P. mirabilis differently than E. coli with respect to susceptibility to surfactants. Sud and Feingold (21) have reported that pretreatment of P. mirabilis cells with polymyxin B sensitizes them to sodium deoxycholate, whereas the reverse situation does not occur. This did not appear to be the case with the surfactants used in the present study and the results indicated that both surfactant and antibiotic must be present at the same time to exert a potentiating effect.
Studies of P. mirabilis by others have provided evidence which suggests that polymyxinsusceptible target sites are present in these organisms but are inaccessible to the antibiotic (20, 23) . The best evidence for this is that L-forms were 400-fold more susceptible to this antibiotic, suggesting that the outer envelope structures play a role in the intrinsic resistance characteristic of these strains (23) . Since S. marcescens is also intrinsically resistant to the polymyxins, it is a strong possibility that its outer envelope structures play a similar role in resistance. K. pneumoniae and E. coli are intrinsically susceptible to the polymyxins and it would be interesting to determine if L-forms of the resistant strains are susceptible to polymyxin B. The simplest mechanism, therefore, to explain the potentiation by surfactantpolymyxin B combinations would be partial loss of outer membrane components or alteration of the outer cell membrane in the resistant strains by these surfactants leading to easier accessibility of the antibiotic to its susceptible target site(s).
Marked enhancement of polymyxin B activity by TCP is most interesting because this compound does not possess the long hydrocarbon chain present in CTAB or L14. Scherr and Bechtle (19) originally reported that compounds such as TCP demonstrated in vitro potentiating activity for a number of antibiotics against strains of Sarcina lutea, S. aureus, and Mycobacterium tuberculosis. Its effect on bacteria is not known, but derivatives of phenoxypropionic acid such as 2(p-chlorophenoxy)-2-methyl propionate have been under investigation in recent years because of their use as agents in the therapy of hyperlipidemia (26) . Experimental evidence suggests that these drugs act as inhibitors of acetyl coenzyme A carboxylase which catalyzes the first committed step in the synthesis of fatty acids by carboxylation of acetyl coenzyme A to form malonyl coenzyme A (14) . Since fatty acids are integral parts of the cell envelope components, inhibition of fatty acid synthesis by TCP would be expected to affect membrane function. It could therefore be profitable to study the effect of TCP, as well as CTAB and L14, on cellular metabolic functions, particularly lipid synthesis, to determine if such affects are sufficent to explain the potentiation phenomenon.
Both CTAB and L14 were found to potentiate the activity of penicillin G against two strains of staphylococci whereas TCP and Tw8O had no effect. None of the surfactants were found to potentiate the activity of penicillin G against a strain of E. coli suggesting that the permeability barrier to this antibiotic was not altered. This is contrary to the effect of EDTA which has been reported to damage the permeability barrier to penicillin G in a strain of E. coli (8) .
It is suspected that the potentiating effect of CTAB and L14 on penicillin G activity against staphylococci is related to penicillinase for the following reasons: (i) neither CTAB nor L14 affected the susceptibility of S. aureus Meuse R to methicillin, a penicillinase-resistant penicillin, whereas susceptibility to penicillin G was increased up to 19-fold (Table 4) ; (ii) both strains were inducible penicillinase producers. A study of the effect of CTAB on the specific activity of penicillinase (Table 5 ) strongly suggested that this surfactant, and presumably L14, interfers with the formation of this enzyme. No direct effect of CTAB on enzyme activity was observed in vitro.
The manner in which CTAB and L14 would affect the synthesis of penicillinase cannot be known without further experimentation. The surfactants might interfere with the induction mechanism although the experimental conditions did not allow us to distinguish between this and interference with enzyme synthesis. Imsande (9) has proposed a working model for the regulation of penicillinase synthesis. According to this model, the inducer (penicillin) is thought to interact with a site on an antirepressor molecule to change its conformation to one which can actively bind to and inactivate a repressor molecule. Inactivation of the repressor molecule permits transcription of the penicillinase structural gene and subsequently enzyme synthesis occurs. Although the repressor substance appears to be located in the cell cyto-ANTIMICROB. AGENTS CHEMOTHER.
on November 3, 2017 by guest http://aac.asm.org/ Downloaded from plasm, it is possible that the antirepressor is bound to the cell membrane (9) . CTAB or L14 may therefore alter the microenvironment of the antirepressor molecule, or bind to the molecule, so that the inducer cannot interact. One could predict from this hypothesis that a mutant strain of staphylococci which is constitutive for penicillinase synthesis would not show an inhibition of enzyme synthesis or potentiation of antibiotic activity by surfactant.
